AFM13 in Relapsed/Refractory Cutaneous Lymphomas

Clinical trial NCT03192202 · COMPLETED

Trial details

NCT number: NCT03192202
Sponsor: Ahmed Sawas
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Cutaneous

Start date: 2017-07-17
Primary completion: 2020-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.